DPA attenuates inflammation in DSS-induced colitis model; modulates pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and anti-inflammatory cytokine (IL-10); inhibits synthesis of pro-inflammatory eicosanoids (PGE2, LTB4). The gene discussed is IL1B; the disease is colitis.